These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3324992)

  • 1. The specificity of serum antibodies to the haemagglutinin of influenza B viruses induced by vaccination.
    Creţescu L; Ioniţă E; Niculescu IT; Coban V; Bogdan C
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):27-33. PubMed ID: 3324992
    [No Abstract]   [Full Text] [Related]  

  • 2. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunological shifts in the blood sera of persons inoculated with influenza vaccines].
    Stepanovskaia LD; Solomko RM; Avratinskiĭ IM; Katuntsevskaia GP; Kiriliuk ZhI; Iampol'skiĭ MP; Burdeniuk EI
    Mikrobiol Zh (1978); 1992; 54(4):70-5. PubMed ID: 1406385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines.
    Mumford JA; Jessett D; Dunleavy U; Wood J; Hannant D; Sundquist B; Cook RF
    Vaccine; 1994 Jul; 12(9):857-63. PubMed ID: 7975864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in human sera after vaccination with inactivated influenza vaccine.
    Loza-Tulimowska M; Semkow R; Michalak T; Wilczyński J
    Acta Virol; 1979 Mar; 23(2):159-61. PubMed ID: 39440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the immunogenicity of aqueous versus aluminium phosphate adsorbed split influenza vaccine C.I.
    Ioniţă E; Lupulescu E; Alexandrescu V; Maţepiuc M; Constantinescu C; Creţescu L; Velea L
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):265-73. PubMed ID: 2519636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
    J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of seroconversion after vaccination against influenza during the epidemic season 1991-1992 in Poland].
    Brydak L; Rudnicka H
    Przegl Epidemiol; 1993; 47(3):275-83. PubMed ID: 8234846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines.
    Ennis FA; Yi-Hua Q; Schild GC
    J Gen Virol; 1982 Feb; 58(Pt 2):273-81. PubMed ID: 7038041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine.
    Unanov SS; Yuminova NV; Akopova II
    Acta Virol; 1982 Dec; 26(6):474-80. PubMed ID: 6132541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of inactivated influenza vaccine containing A/Niigata/102/81 (H3N2). Increase of HAI antibodies to different variants of the subtype.
    Takeuchi Y; Takahashi M; Satsuta K; Hatta S; Suzuki H; Ogawa Y; Hirano S; Takahashi K; Yamazi Y
    Nihon Ika Daigaku Zasshi; 1985 Oct; 52(5):607-10. PubMed ID: 4066903
    [No Abstract]   [Full Text] [Related]  

  • 15. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
    Stech J
    Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Live influenza vaccine].
    Smorodintsev AA
    Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315
    [No Abstract]   [Full Text] [Related]  

  • 17. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age.
    Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE
    Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody formation and preservation against the envelope antigens of influenza virus subtype A(H3N2) after infection and vaccination].
    Stumpa A; Tůmová B
    Tr Inst Im Pastera; 1982; 59():23-8. PubMed ID: 6764986
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vaccinal prevention of influenza in children].
    Zykov MP; Vasil'eva RI
    Tr Inst Im Pastera; 1982; 58():30-8. PubMed ID: 6764981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.